Account

New to ADSS? Open an
account now to get started.

OR

Already have an account?

Add funds to your ADSS account

Account

New to ADSS? Open an
account now to get started.

Add funds to your ADSS account

Trends & Analysis
News

USD gains amid Fed rate cut speculations

News

Is the silver squeeze back?

News

Li Auto’s stock hits a speedbump on Q1 results

News

Gold closes week higher on rate cut speculations

News

Week Ahead Preview: 20th of May

News

Walmart’s stock hits record high on Q1 results

Trends & Analysis
News

USD gains amid Fed rate cut speculations

News

Is the silver squeeze back?

News

Li Auto’s stock hits a speedbump on Q1 results

News

Gold closes week higher on rate cut speculations

News

Week Ahead Preview: 20th of May

News

Walmart’s stock hits record high on Q1 results

Johnson & Johnson (JNJ) – Share price chart, background, and sentiment

Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.

Johnson & Johnson (JNJ) is an American multinational corporation in the pharmaceutical industry, and it has become a household name around the world since its founding in 1886 in New Brunswick, New Jersey. The company, together with its subsidiaries, develops medical devices, pharmaceuticals, and consumer packaged goods in the healthcare field.

Johnson & Johnson Share Price Today

Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.

Johnson & Johnson’s Consumer Health segment is one of the most well-known, consisting of skincare, health, beauty, oral care, baby product, and medication brands such as CLEAN & CLEAR, NEUTROGENA, LISTERINE, TYLENOL, BENADRYL, BAND-AID, and more. The company pharmaceutical segment also provides over the counter and prescription medication, while its MedTech segment offers electrophysiology and neurovascular care products.

Johnson & Johnson went public on the NYSE in September 1944. It has enjoyed stability in the financial markets over the decades, and it currently has a market capitalisation of $442.28 billion. Institutional holders make up more than 70% of all its shareholders, with Vanguard, Blackrock, and State Street Corporation being the top three.

Trade Johnson & Johnson CFDs with ADSS, the ultimate trading destination.

Why trade equities with ADSS?

Competitive prices

Enjoy highly competitive CFD pricing across global markets.

Every market’s waiting

Trade CFDs globally and locally across asset classes.

Enhanced trading experience

Benefit from using our comprehensive and customisable trading platform.

Related equities

Platform

Your new trading adventure starts today

Discover our intuitive, next-generation trading platform


Site by Pink Green
© ADSS 2024


Investing in CFDs involves a high degree of risk that you will lose your money due to the use of leverage, particularly in fast moving markets, where a relatively small movement in the price can lead to a proportionately larger movement in the value of your investment. This can result in loses that exceed the funds in your account. You should consider whether you understand how CFDs work and you should seek independent advice if necessary.

ADS Securities LLC (“ADSS”) is authorised and regulated by the Securities and Commodities Authority (“SCA”) in the United Arab Emirates as a trading broker for Over the Counter (“OTC”) Derivatives contracts and foreign exchange spot markets. ADSS is a limited liability company incorporated under United Arab Emirates law. The company is registered with the Department of Economic Development of Abu Dhabi (No. 1190047) and has its principal place of business at 8th Floor, CI Tower, Corniche Road, P.O. Box 93894, Abu Dhabi, United Arab Emirates.

The information presented is not directed at residents of any particular country outside the United Arab Emirates and is not intended for distribution to, or use by, any person in any country where the distribution or use is contrary to local law or regulation.

ADSS is an execution only service provider and does not provide advice. ADSS may publish general market commentary from time to time. Where it does, the material published does not constitute advice, or a solicitation, or a recommendation to a transaction in any financial instrument. ADSS accepts no responsibility for any use of the content presented and any consequences of that use. No representation or warranty is given as to the completeness of this information. Anyone acting on the information provided does so at their own risk.